StockVS

NASDAQ · Conglomerates · USD

Genenta Science S.p.A. (GNTA) Stock Analysis

Genenta Science S.p.A. (GNTA) is a Conglomerates stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

GNTA

$0.64

+$0.03 (+4.07%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare GNTA with… →

GNTA Key Statistics

As of Oct 21, 2026
Trading
Open
$0.61
Previous Close
$0.62
Day's Range
0.61–0.66
52-Week Range
0.55–10.00
Volume
31.87K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.76
Valuation
Market Cap
$30.86M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.37
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$6.53M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
48.22M
1-Year Return
−80.55%
Dividend and dates
Avg Volume
56.06K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, GNTA closed at $0.64, −80.55% over 1 year.

Genenta Science S.p.A. (GNTA) has a market capitalization of $30.86M.

In fiscal 2025, GNTA reported revenue of $0.00.

GNTA Stock Return by Calendar Year

Genenta Science S.p.A. (GNTA) return since Dec 2021: what $10,000 became

1 year
$10,000 $1,945
−80.55%
3 years
$10,000 $1,280
−87.20%
Since Dec 2021
$10,000 $582
−94.18%

If you had invested $10,000 in Genenta Science S.p.A. (GNTA) at the close on December 15, 2021, the earliest close on record here, it would have been worth $582 at the close on October 21, 2026: −94.18% in total, −44.38% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−57.05%
2025−65.75%
2024−12.12%
2023−10.00%
2022−49.83%
2021 (partial year)−0.35%

As of October 21, 2026.

GNTA Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$6.53M—
2024$0.00−$8.91M—
2023$0.00−$11.65M—
2022$0.00−$8.48M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$6.60M−$6.53M—
2024$0.00—−$9.76M−$8.91M—
2023$0.00—−$11.73M−$11.65M—
2022$0.00—−$11.04M−$8.48M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

Analysis

Data-derived

Company Overview

Genenta Science S.p.A. (GNTA) carries a market capitalisation of $30.86M. The company sits in the Industrials sector, in the Conglomerates industry. The company reports 9 employees.

GNTA last closed at $0.64 on October 21, 2026. That is +$0.03 (+4.07%) against the previous close. Over the past 52 weeks the price has ranged from $0.55 to $10.00. The latest close sits 16.36% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $0.00. The same year closed with a net loss of $6.53M. Trailing earnings per share are −0.37.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

Over the trailing twelve months the total return is −80.55%. Across 3 years the annualized return works out at −49.60%. The reported beta is 0.76. Annualized volatility over the trailing 4 years is 107.96%.

Growth & Income

The record shows no dividend for GNTA.

Across the complete calendar years on file, 2023 returned −10.00% and 2025 returned −65.75%. Of the 4 complete calendar years on file, 0 finished higher. So far in 2026 the total return is −57.05%.

Peer Comparison

Genenta Science S.p.A. (GNTA) operates in the Conglomerates industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Genenta Science S.p.A. GNTA $30.86M —
3M Company MMM $90.12B 26.1
Honeywell International Inc. HON $68.06B 7.9
Valmont Industries, Inc. VMI $8.66B 17.5

The Conglomerates industry average P/E ratio is 9.9x. Genenta Science S.p.A. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Conglomerates Stocks

View all Conglomerates stocks →

Popular Industrials Stocks

View all Industrials stocks →

About Genenta Science S.p.A.

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Visit website →